STRATEC SE (Frankfurt: SBS; Prime Standard) held its Annual General Meeting on June 23, 2026, where shareholders approved all proposed resolutions with clear majorities. The meeting, which saw 70.1 percent of the company's registered share capital represented, resolved to distribute a dividend of EUR 0.60 per share for the 2024 financial year, unchanged from the previous year. The total dividend payout amounts to EUR 7.3 million and will be paid to shareholders via their depositing banks on June 26, 2026.
In addition to the dividend resolution, shareholders approved the actions of the Board of Management and the Supervisory Board. They also elected PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft (PwC), Frankfurt am Main, as the auditor for the 2026 financial year. The remuneration report was also approved by the shareholders.
STRATEC SE designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and life sciences, and offers complex consumables for diagnostic and medical applications. The company covers the entire value chain from development to production and quality assurance. Its partners market the systems, software, and consumables as complete system solutions to laboratories, blood banks, and research institutes worldwide.
Further information about the Annual General Meeting, including detailed voting results, can be found at www.stratec.com/agm. Details about the company and its shares, which are traded in the Prime Standard segment of the Frankfurt Stock Exchange under ISIN DE000STRA555, are available at www.stratec.com.
The consistent dividend reflects STRATEC's commitment to shareholder value and its stable financial performance. The approval of all agenda items underscores shareholder confidence in the company's strategic direction and governance. With a strong representation at the meeting, the outcomes signal continued support for STRATEC's management and its operational focus on innovation in diagnostics and life sciences.
